A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis

Study Purpose:

To determine if long-term topiramate therapy is safe and slows disease progression in patients with ALS.

Study Status:

Not recruiting

Disease:

Amyotrophic Lateral Sclerosis (ALS) , Familial ALS , Sporadic ALS

Study Type:

Interventional

Type of Intervention:

Drug Trial

Intervention Name:

Placebo:

Phase:

N/A

Study Chair(s)/Principal Investigator(s):

Merit Cudkowicz, Massachusetts General Hospital

Clinicaltrials.gov ID:

Neals Affiliated?

Yes

Coordinating Center Contact Information